VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,424,975 | -38.2% | 561,337 | -5.7% | 0.00% | -100.0% |
| Q2 2023 | $3,924,345 | -3.1% | 595,500 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $4,048,762 | -6.5% | 596,283 | +1.8% | 0.00% | 0.0% |
| Q4 2022 | $4,330,710 | -26.3% | 586,023 | -1.4% | 0.00% | 0.0% |
| Q3 2022 | $5,875,000 | -9.7% | 594,590 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $6,509,000 | -3.6% | 597,141 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $6,751,000 | -45.7% | 596,909 | -24.7% | 0.00% | -50.0% |
| Q4 2021 | $12,431,000 | -9.3% | 792,251 | -0.9% | 0.00% | 0.0% |
| Q3 2021 | $13,703,000 | -22.3% | 799,472 | -2.5% | 0.00% | -33.3% |
| Q2 2021 | $17,642,000 | +87.7% | 820,153 | +31.1% | 0.00% | +50.0% |
| Q1 2021 | $9,397,000 | +10.0% | 625,670 | -3.8% | 0.00% | 0.0% |
| Q4 2020 | $8,544,000 | +29.3% | 650,232 | -4.9% | 0.00% | +100.0% |
| Q3 2020 | $6,607,000 | -18.8% | 683,927 | -3.9% | 0.00% | -50.0% |
| Q2 2020 | $8,141,000 | +9.1% | 711,551 | -1.2% | 0.00% | 0.0% |
| Q1 2020 | $7,460,000 | -36.5% | 720,076 | +0.6% | 0.00% | -33.3% |
| Q4 2019 | $11,749,000 | +20.7% | 715,950 | -2.3% | 0.00% | +50.0% |
| Q3 2019 | $9,733,000 | -2.2% | 732,933 | +3.7% | 0.00% | 0.0% |
| Q2 2019 | $9,957,000 | -22.7% | 706,666 | +1.0% | 0.00% | -33.3% |
| Q1 2019 | $12,875,000 | -29.2% | 699,728 | +0.6% | 0.00% | -40.0% |
| Q4 2018 | $18,173,000 | +12.8% | 695,438 | -0.9% | 0.01% | +25.0% |
| Q3 2018 | $16,111,000 | +25.0% | 702,021 | +3.8% | 0.00% | +33.3% |
| Q2 2018 | $12,884,000 | +30.8% | 676,300 | +15.7% | 0.00% | 0.0% |
| Q1 2018 | $9,853,000 | +12.1% | 584,761 | +1.2% | 0.00% | +50.0% |
| Q4 2017 | $8,786,000 | -17.1% | 578,031 | -2.3% | 0.00% | -33.3% |
| Q3 2017 | $10,593,000 | +8.7% | 591,786 | -1.0% | 0.00% | 0.0% |
| Q2 2017 | $9,747,000 | +35.7% | 597,928 | +16.5% | 0.00% | +50.0% |
| Q1 2017 | $7,183,000 | -7.1% | 513,094 | +5.9% | 0.00% | 0.0% |
| Q4 2016 | $7,729,000 | -3.6% | 484,552 | +0.5% | 0.00% | 0.0% |
| Q3 2016 | $8,021,000 | +48.5% | 482,019 | -0.1% | 0.00% | 0.0% |
| Q2 2016 | $5,401,000 | +22.1% | 482,597 | -8.8% | 0.00% | +100.0% |
| Q1 2016 | $4,425,000 | -6.1% | 529,253 | +4.6% | 0.00% | -50.0% |
| Q4 2015 | $4,711,000 | -12.5% | 506,051 | +6.0% | 0.00% | 0.0% |
| Q3 2015 | $5,385,000 | +2.5% | 477,431 | +15.3% | 0.00% | 0.0% |
| Q2 2015 | $5,256,000 | +22.1% | 414,156 | -10.5% | 0.00% | +100.0% |
| Q1 2015 | $4,303,000 | -32.9% | 462,602 | +3.3% | 0.00% | -50.0% |
| Q4 2014 | $6,412,000 | +52.9% | 447,798 | +10.9% | 0.00% | +100.0% |
| Q3 2014 | $4,193,000 | -35.4% | 403,924 | +0.8% | 0.00% | -50.0% |
| Q2 2014 | $6,486,000 | -10.9% | 400,864 | -10.5% | 0.00% | 0.0% |
| Q1 2014 | $7,281,000 | +19.1% | 448,087 | -9.0% | 0.00% | 0.0% |
| Q4 2013 | $6,111,000 | +24.7% | 492,406 | +10.1% | 0.00% | 0.0% |
| Q3 2013 | $4,899,000 | +51.9% | 447,394 | +12.1% | 0.00% | +100.0% |
| Q2 2013 | $3,226,000 | – | 399,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |